Cardiocom’s new pulse oximeter is specifically suited for the home telehealth environment and was registered with the FDA in late 2009.

Cardiocom said that its vertical integration ensures customers the quality, custom telehealth solutions at an affordable cost. Its suite of telehealth solutions has proven to significantly decrease unnecessary inpatient admissions and improve quality of care for integrated health systems, home health agencies, managed care organizations and specialty care companies.

Daniel Cosentino, CEO and president of Cardiocom, said: “Cardiocom’s segmented telehealth device platforms and vital sign monitoring peripherals provide a highly efficient and effortless user experience.

“Cardiocom’s decade of experience in telehealth, innovative products, and ancillary nurse service provides the best telehealth solutions to improve care for patients with complex chronic conditions.”